Last reviewed · How we verify
NCT06572696: UEASJPRAP
Ultrasonographic Evaluation of Asymptomatic Shoulder Joint Pathologies in Rheumatoid Arthritis Patients
trial testing Shulder Ultrasound in Rheumatoid Arthritis in 60 participants. Currently enrolling.
2 September 2024
Quick facts
| Lead sponsor | Fatih Sultan Mehmet Training and Research Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 12 August 2024 |
| Primary completion | 2 September 2024 |
| Estimated completion | 2 September 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Shulder Ultrasound
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Shoulder Injuries and Disorders — all drugs for Shoulder Injuries and Disorders →
Sponsor
Fatih Sultan Mehmet Training and Research Hospital
Who can join
Adults 18 to 75, any sex, with Rheumatoid Arthritis or Shoulder Injuries and Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ultrasonographic determination of changes and degree of damage in asymptomatic shoulder joint periarticular structures in RA patients and comparison with healthy controls.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ultrasonographic Evaluation of Asymptomatic Shoulder Involvement in Rheumatoid Arthritis: A Prospective Case-Control Study.
Doğan YE, Çınar Ç, Öneş K, Kütük B, et al · · 2026 · PMID 42194627 · DOI 10.3390/jcm15103666
Verify or expand the search:
- PubMed search for NCT06572696
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Fatih Sultan Mehmet Training and Research Hospital trials
Trials by the same sponsor.
- NCT07589582 — Active Noise-Cancelling Headphones Reduce Operative Time and Improve Procedural Consistency in ACL Reconstruction l · NA · active not recruiting
- NCT07523828 — Laryngeal Edema Assessment by Cuff Leak Test and Ultrasound in ICU Patients and Its Relationship With Weaning Success · not yet recruiting
- NCT07487038 — The Efficacy and Safety of a Single-Dose Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis · not yet recruiting
- NCT07485465 — Lymphoedema Diagnosis and Treatment · not yet recruiting
- NCT07451925 — Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06572696 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatih Sultan Mehmet Training and Research Hospital
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06572696.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing